Nuwellis selected as recipient of the Governor’s Award for International Trade

0

Nuwellis Recognized As A Minnesota Company With Outstanding Progress And Success In Foreign Markets

EDEN PRAIRIE, Minnesota, October 19, 2021 (GLOBE NEWSWIRE) – Nuwellis, Inc. (NASDAQ: NUWE) received the 2021 Governor’s International Trade Award from Governor of Minnesota Tim Walz last week. This award recognizes Minnesota companies that develop and continue to grow a significant portion of their business in overseas markets, increasing or retaining jobs in Minnesota, and developing new approaches to compete globally. It also recognizes the huge positive effect that exports and trade have on the state’s overall economy.

“We are honored to be recognized as recipients of the Governor’s Award for International Business,” said Nestor Jaramillo, Jr., President and CEO of Nuwellis. “We can attribute this success to our hardworking and diverse employees, who – even during a pandemic – continue to educate hospitals and providers on the benefits of using the Aquadex SmartFlow® System to treat adult and pediatric patients overburdened with liquid weighing 20 kg or more. in the United States and abroad.

Nuwellis is a medical device company that develops, manufactures and markets the Aquadex SmartFlow® System for Ultrafiltration Therapy, an effective treatment option for fluid overloaded intensive care, heart failure and pediatric patients. Nuwellis has increased the number of jobs in Minnesota due to increased demand for products, both nationally and internationally.

“This year’s winners are among the many companies based in Minnesota, or with locations in Minnesota, that deliver our state’s products to all corners of the world,” Governor Walz said. “A diverse global business network helps ensure Minnesota’s economy remains strong as we continue to demonstrate our ingenuity and innovation on the global stage. “

Nuwellis currently has operations in the United States and Europe, the Middle East, Brazil and South East Asia, and has recently expanded its business to Austria, Israel and the United Arab Emirates. The company now has distribution agreements covering 18 countries outside of the United States. In September 2021, Nuwellis received CE mark certification for its 24-hour blood circuit set in order to market the circuit in the European Union and other countries that recognize the certification, thereby expanding access to its therapy. exclusive ultrafiltration.

Nuwellis was one of five companies honored in the awards, recognized in the service category for small and medium enterprises (less than 500 employees). The winners were celebrated in a ceremony on Friday, October 15, 2021.

About Nuwellis
Nuwellis, Inc. (Nasdaq: NUWE) is a medical device company dedicated to transforming the lives of patients with fluid overload through science, collaboration and innovation. The Company is focused on the development, manufacture and commercialization of the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Eden Prairie, Minnesota, with a wholly owned subsidiary in Ireland.

About the Aquadex SmartFlow System
The Aquadex SmartFlow System provides clinically proven therapy using a simple, flexible and predictable method of removing excess fluid in patients with hypervolemia (fluid overload). The Aquadex SmartFlow System is indicated for temporary (up to 8 hours) or prolonged (more than 8 hours in patients requiring hospitalization) use in adult and pediatric patients weighing 20 kg or more whose fluid overload does not respond to medical management, including diuretics. All treatments should be administered by a healthcare provider, in an outpatient or inpatient clinic setting, on the prescription of a physician, both of whom have received training in extracorporeal therapy.

CONTACT: Media Contact: Laurel Hood Health+Commerce [email protected]
Share.

Comments are closed.